NL repository
menu
검색
Library
Browse
Communities & Collections
By Date
Authors
Titles
Subject
My Repository
My Account
Receive email updates
Edit Profile
DSpace at EWHA
약학대학
약학과
Journal papers
View : 667 Download: 0
Histone deacetylase inhibitors: A novel class of therapeutic agents in diabetic nephropathy
Title
Histone deacetylase inhibitors: A novel class of therapeutic agents in diabetic nephropathy
Authors
Lee H.B.
;
Noh H.
;
Seo J.Y.
;
Yu M.R.
;
Ha H.
Ewha Authors
하헌주
SCOPUS Author ID
하헌주
Issue Date
2007
Journal Title
Kidney International
ISSN
0085-2538
Citation
Kidney International vol. 72, no. SUPPL. 106, pp. S61 - S66
Indexed
SCI; SCIE; SCOPUS
Document Type
Conference Paper
Abstract
Histone deacetylase (HDAC) inhibitors are currently being tested as anticancer agents in clinical trials. Chromatin remodeling, such as through histone acetylation, is a fundamental phenomenon in eukaryotic cell biology, bearing implications to numerous physiological and pathological phenomena. Here, we discuss recent data from our own laboratory and those of others demonstrating antifibrotic and renoprotective effect of HDAC inhibitors in diabetic kidneys, and the possible mechanisms including the role of reactive oxygen species. HDAC inhibitors may prove to be a novel class of multitarget agents in the treatment of diabetic nephropathy. © 2007 International Society of Nephrology.
DOI
10.1038/sj.ki.5002388
Appears in Collections:
약학대학
>
약학과
>
Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML
Show full item record
Find@EWHA
트윗하기
BROWSE
Communities & Collections
By Date
Authors
Titles
Subject